<?xml version="1.0" encoding="UTF-8"?>
<p>Male patient, 26 years old, kitchen assistant, originated from Taxco, Guerrero and living there until he emigrated to Texas, United States, in 2016, where he was diagnosed with B lymphoblastic leukemia in January 2017. He received four cycles of unspecified chemotherapy with apparent remission of the disease and came back to Mexico (Cuernavaca, Morelos). He was admitted to the National Institute of Cancer in Mexico City in November 2017, where he was diagnosed with early relapse. From November 2017 to January 2018, he received chemotherapy for relapse with BFM like protocol (L-Asparaginase, Vincristine, Daunorubicin, and Prednisone). He did not receive any antifungal prophylaxis. On day +23 he was presented with febrile neutropenia, with no etiologic agent identified. An empirical treatment of five days of Meropenem was administered, with resulting in fever remission. He was discharged 6 days after his admission, asymptomatic but with persistent neutropenia.</p>
